Abridge Stock
Abridge offers an AI-powered platform that helps users capture and summarize important information during healthcare conversations. The company focuses on providing tools that automatically transcribe and highlight key points from doctor-patient interactions, ensuring patients can easily review and retain critical health information.
Sign up for SecondMarket® to view the market and buy or sell Abridge Stock
Buy + SellAbridge Stock Price Chart
The below graph shows the estimated historical Abridge stock price as of last month, known as the Tape D® price. The Abridge Tape D® price is based on market activity, publicly-sourced valuation data, and other proprietary information. Create an account to see the current estimated Abridge price per share.
Abridge Stock Price Per Share
Abridge Funding
Sign up to gain insights into Abridge funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series E | Jun 24, 2025 | 300.00M | ||
| Series D | Feb 17, 2025 | 250.00M | ||
| Series C | Feb 22, 2024 | 141.10M | ||
| Series B | Oct 26, 2023 | 30.00M | ||
| Series A | Aug 11, 2022 | 12.50M | ||
| Series A | Mar 26, 2020 | 10.00M | ||
| Series Seed | Jan 31, 2019 | 5.05M |
See Abridge Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Abridge Stock Valuation + Share Prices
View real-time Tape D® data on Abridge stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Abridge Management Team
-
CFO
Sagar Sanghvi
-
Chief Commercial Officer
Brian Wilson
-
Chief Product Officer
Mario Queiro
-
Co-Founder, CEO, Director
Shivdev Rao
-
Co-Founder, CTO
Sandeep Konam
-
COO
Julia Chou
-
CTO, Chief Science Officer
Zack Lipton
-
Board Member
Sebastian Duesterhoeft
-
Board Member
Will Reed
-
Board Member
Andy Weissman
Abridge Major Investors
-
Wittington Ventures
-
Whistler Capital Partners
-
UPMC Enterprises
-
Union Square Ventures
-
Pillar Companies
-
KdT Ventures
-
Bessemer Venture Partners
Learn More About Abridge Stock
Buy Abridge Stock
01Abridge stock does not trade on public stock exchanges. Abridge stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Abridge stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Abridge Stock
02Abridge Stock does not trade on public stock exchanges. In order to sell Abridge shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Abridge Stock Price
03Nasdaq Private Market estimates that Abridge price per share was $167.13 last month. This Abridge share value estimate (known as the Tape D™ price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With Tape D premium for investors, you can get visibility into the Abridge share price today and the factors driving Abridge valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
Abridge Stock Ticker Symbol
04There is no ticker symbol for Abridge stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Abridge Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Abridge stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Abridge Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Abridge stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Abridge Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Abridge IPO
08Abridge is a private company and has not had an IPO. There is currently no Abridge IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Abridge IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Abridge Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
